These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12802894)

  • 1. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G
    Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
    Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
    Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
    N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.
    Van Roy N; Vandesompele J; Berx G; Staes K; Van Gele M; De Smet E; De Paepe A; Laureys G; van der Drift P; Versteeg R; Van Roy F; Speleman F
    Genes Chromosomes Cancer; 2002 Oct; 35(2):113-20. PubMed ID: 12203774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
    Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
    Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M; Berthold F; Edler L; Schwab M; Amler LC
    Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
    Lastowska M; Roberts P; Pearson AD; Lewis I; Wolstenholme J; Bown N
    Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
    Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
    Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and genetic studies on the region of translocation and duplication in the neuroblastoma cell line NGP at the 1p36.13-p36.32 chromosomal site.
    Casciano I; Marchi JV; Muresu R; Volpi EV; Rozzo C; Opdenakker G; Romani M
    Oncogene; 1996 May; 12(10):2101-8. PubMed ID: 8668335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma.
    Laureys G; Versteeg R; Speleman F; van der Drift P; Francke U; Opdenakker G; Van Roy N
    Eur J Cancer; 1995; 31A(4):523-6. PubMed ID: 7576958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
    Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
    Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
    Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections.
    Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J
    Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
    Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.